Prebiotic FOS, Blood Sugar, and Gut Health

How yacon root — a traditional Andean food rich in fructooligosaccharides — feeds beneficial gut bacteria, lowers blood sugar after meals, and supports insulin sensitivity

Yacon is a root vegetable native to the Andes, eaten for centuries across Peru, Bolivia, and Ecuador. It looks like a sweet potato on the outside, but inside it stores most of its carbohydrates not as starch but as fructooligosaccharides — prebiotic fibers that the human digestive system cannot absorb. This means yacon is unusually low in usable calories despite its sweet taste, and the FOS it contains passes intact to the colon where it selectively feeds Bifidobacterium and Lactobacillus species. A landmark 120-day clinical trial found that consuming yacon syrup daily produced significant reductions in body weight, waist circumference, fasting insulin, and insulin resistance in obese women [1]. A more recent crossover trial confirmed that a single serving of yacon syrup meaningfully lowers both glucose and insulin levels in the hour following a meal [4]. For anyone managing blood sugar or looking to increase prebiotic fiber without adding much digestible carbohydrate, yacon is one of the more evidence-backed options available.

What Makes Yacon Different

Yacon (Smallanthus sonchifolius) belongs to the sunflower family and has been cultivated in Andean highland communities for at least a thousand years. Unlike most root vegetables, which store energy as starch, yacon stores carbohydrates primarily as fructooligosaccharides (FOS) — chains of fructose molecules typically 3–10 units long. These are structurally similar to inulin (found in chicory root and Jerusalem artichoke) but with a shorter average chain length, which makes yacon FOS particularly accessible to colonic bacteria.

The FOS content of yacon root ranges from roughly 35–70% of dry weight depending on the variety and storage conditions [2]. After harvest, FOS gradually converts to free fructose and glucose, so freshness matters — dried, processed, or syrup forms retain more FOS than roots that have been stored at room temperature for weeks.

Alongside FOS, yacon contains a range of phenolic compounds including caffeic acid, chlorogenic acid, and ferulic acid — the same antioxidant acids found in coffee and blueberries [2]. These phenolics contribute antioxidant capacity and may have anti-inflammatory effects, though most research on yacon has focused on the FOS fraction.

How FOS Feeds the Gut

When FOS reaches the colon undigested, it acts as a selective substrate for fermentation by beneficial bacteria — particularly Bifidobacterium and Lactobacillus species. These bacteria produce short-chain fatty acids (SCFAs) as fermentation byproducts, most importantly butyrate, propionate, and acetate. Butyrate is the primary energy source for the colonocytes that line the gut, maintaining the physical integrity of the intestinal wall. Propionate and acetate enter the portal circulation and influence liver metabolism and systemic inflammation.

What makes FOS selectively prebiotic is that pathogenic bacteria — including Clostridium difficile and several Salmonella strains — cannot efficiently ferment FOS. So increasing FOS intake tends to shift the microbial balance toward beneficial species without providing meaningful competitive advantage to pathogens.

Animal feeding studies with yacon FOS consistently show promotion of Bifidobacterium and Lactobacillus growth, increases in cecal SCFA concentration, and improvements in colonic tissue density (a marker of colon cell health) [2]. The dose at which these effects appear in animal models corresponds to roughly 10–20g of FOS per day in humans.

Blood Sugar and Insulin Resistance

The blood sugar effects of yacon operate through several overlapping mechanisms. First, because FOS is not absorbed in the small intestine, yacon contributes relatively few digestible calories and does not drive meaningful blood glucose rises on its own. Second, FOS fermentation produces SCFAs that signal through free fatty acid receptors in gut enteroendocrine cells, stimulating the release of glucagon-like peptide 1 (GLP-1) and peptide YY — hormones that slow gastric emptying, stimulate insulin secretion in proportion to glucose, and reduce appetite.

In the Genta et al. clinical trial, obese pre-menopausal women with mild insulin resistance consumed either yacon syrup or a placebo for 120 days in a double-blind design [1]. The yacon group received approximately 0.14g of FOS per kilogram of body weight per day — roughly 7–10g for most participants. Fasting insulin fell significantly (from ~13 to ~9 mIU/L), as did the HOMA-IR index of insulin resistance (from ~2.9 to ~2.0). Body weight decreased by an average of 3.7kg and waist circumference by 3.8cm. Fasting blood glucose itself was not significantly changed, suggesting the benefit was primarily through improved insulin sensitivity rather than a direct glucose-lowering effect.

The postprandial picture is different. A 2019 randomized crossover trial enrolled 40 women who consumed a standard breakfast with either 40g of yacon syrup (containing 14g of FOS) or a placebo, with a washout period between arms [4]. Blood glucose and insulin were measured at intervals up to 120 minutes after the meal. Glucose was significantly lower at the 30-minute mark and insulin was lower at 15, 30, and 45 minutes in the yacon group. The effect size was clinically meaningful — not a marginal statistical difference but a clear flattening of the post-meal spike.

Practical Forms and Dosing

Yacon is available in several forms, each with different FOS concentrations:

Yacon syrup is the most standardized and widely used form. It is produced by cold-pressing the juice from yacon roots and concentrating it under low heat to preserve the FOS. A good-quality yacon syrup contains roughly 35–50% FOS by weight. The dose used in clinical trials is typically 1–2 teaspoons (5–10ml) before meals, providing around 3–7g of FOS per serving. This is the form with the best clinical evidence.

Dried yacon root or yacon chips retain FOS if dried at low temperature but are less standardized. A 30g serving provides roughly 5–10g of FOS depending on freshness and variety.

Yacon powder made from dehydrated root is used as a sweetener with a mild, sweet, slightly earthy taste. It has a low glycemic impact and can substitute for a portion of sugar in baked goods and smoothies.

Fresh yacon root (available at some Latin American markets and specialty grocers) can be eaten raw — it has a crisp, juicy texture similar to water chestnut with a mild sweetness. It spoils relatively quickly and converts some FOS to free sugars in storage.

Starting slowly is advisable. Rapid increases in prebiotic fiber intake commonly cause gas and bloating as the gut microbiome adjusts. Beginning with 5g of FOS daily and increasing over two to three weeks lets the beneficial bacteria population expand without producing excessive fermentation byproducts in the early stages. Most people tolerate 10–15g of FOS daily well after an adjustment period.

See our Chicory Root page for a related prebiotic with similar FOS content, and our Resistant Starch page for more on how prebiotic fibers feed the colon.

Evidence Review

Long-term Clinical Trial: Obesity and Insulin Resistance (Genta et al., 2009)

This is the most rigorous human trial on yacon to date — a double-blind, placebo-controlled study running for 120 days [1]. Participants were 55 pre-menopausal women with obesity (BMI ≥ 30) and mild insulin resistance recruited from an outpatient clinic in Argentina. Women with diabetes, hypertension requiring medication, or hepatic or renal disease were excluded. Participants were randomized to receive either yacon syrup (at doses providing 0.29g or 0.14g FOS per kg body weight per day) or a calorie-matched placebo syrup. All participants received dietary counseling to maintain their usual diet, and caloric intake was monitored across the study.

At the end of the 120-day period, the yacon-treated groups showed statistically significant reductions in body weight (mean −3.7kg in the higher-dose group versus no change in placebo), waist circumference (−3.8cm), and BMI. Fasting serum insulin decreased from a mean of 13.2 to 9.3 mIU/L in the FOS group, and the HOMA-IR index fell from 2.87 to 2.00 — both statistically significant at p < 0.001. Fasting blood glucose was not significantly changed, suggesting the primary mechanism is improved insulin sensitivity rather than direct glucose lowering.

Importantly, gastrointestinal tolerance was assessed throughout. The dose of 0.14g FOS/kg/day (roughly 7–10g for most participants) was well tolerated. The higher dose of 0.29g/kg/day produced mild gastrointestinal complaints in some participants — primarily bloating and increased flatulence — suggesting a practical upper limit for daily FOS intake. LDL cholesterol fell modestly in the yacon groups.

Limitations: the study was conducted in a single center in Argentina with a specific demographic (obese pre-menopausal women with insulin resistance); effects in men, normal-weight individuals, and those with type 2 diabetes are not established from this trial. The study cannot distinguish between the FOS effect and possible effects from other yacon bioactives. Nonetheless, the 120-day duration, blinded design, and objective metabolic endpoints make this the strongest available human evidence for yacon's insulin-sensitizing effects.

Prebiotic Characterization and Gut Effects (Campos et al., 2012)

This study from the Universidad Peruana de Ciencias Aplicadas characterized FOS and phenolic content across 35 yacon accessions (genetic varieties) and evaluated the prebiotic effects of a high-FOS diet in rodents [2]. FOS content across varieties ranged from 6.4 to 65g per 100g dry weight — a tenfold variation highlighting the importance of variety and cultivation conditions. Total phenolic content (measured as chlorogenic acid equivalents) ranged from 7.9 to 30.8mg/g dry weight; antioxidant capacity varied proportionally.

In the animal feeding component, rats were fed diets enriched with yacon FOS for 4 weeks. Compared to controls, the yacon FOS diet produced a significant increase in Bifidobacterium and Lactobacillus counts in cecal contents (assessed by culture-based methods), increased concentrations of total short-chain fatty acids in the cecum, and measurably greater cecal crypt depth — a histological marker of colonic cell proliferation and gut wall health. These findings confirm the prebiotic activity of yacon FOS in a controlled animal model.

Limitations: the animal model used healthy rodents without disease, so the magnitude of benefit in humans with gut dysbiosis or metabolic disease may differ. The wide variation in FOS content between yacon varieties underscores why standardized extracts or syrups with known FOS concentrations offer more predictable prebiotic effects than raw root consumption from unknown sources.

Comprehensive Review: FOS and Disease Prevention (Caetano et al., 2016)

This narrative review published in Nutrients synthesized available research on yacon FOS across human, animal, and in vitro studies with a focus on chronic disease prevention [3]. The authors identified consistent evidence across model systems for FOS-mediated prebiotic effects (promotion of Bifidobacterium, Lactobacillus, SCFA production), anti-obesity effects (reduced adipogenesis in animal models, reduced caloric intake via satiety hormones), and blood sugar modulation (GLP-1 stimulation, reduced postprandial glucose in animal models).

The review also discussed anti-cancer effects observed in rodent colorectal cancer models, where yacon FOS supplementation reduced aberrant crypt foci (precancerous lesions) and modulated expression of proteins involved in apoptosis and cell proliferation. These findings are mechanistically coherent but limited to animal models and are not a basis for clinical cancer prevention claims.

The authors concluded that yacon is a promising functional food for metabolic health, emphasizing that the clinical evidence base — while encouraging — is limited relative to the volume of preclinical data. They called for larger, longer randomized controlled trials in diverse populations to establish dose-response relationships and determine which patient populations benefit most.

Postprandial Glycemic Effects: Randomized Crossover Trial (Adriano et al., 2019)

This double-blind, randomized, crossover trial directly tested whether a single dose of yacon syrup reduces the blood glucose and insulin spike following a standard meal [4]. Forty women were enrolled: 20 with normal weight and 20 with grade I obesity (BMI 30–35). In each arm, participants consumed a standardized breakfast with either 40g of yacon syrup (providing 14g of FOS) or 40g of a placebo syrup matched for color and taste. Blood was drawn at 0, 15, 30, 45, 60, 90, and 120 minutes after consumption. After a washout period, participants crossed over to the other condition.

Glucose was significantly lower in the yacon group at 30 minutes post-meal (p < 0.05). Insulin was significantly lower at 15, 30, and 45 minutes. The incremental area under the curve (iAUC) for both glucose and insulin was lower in the yacon arm, indicating that the FOS meaningfully attenuated the overall post-meal metabolic response. The effect was observed in both normal-weight and obese participants.

The 14g FOS dose used here is larger than typical daily consumption in clinical trials and corresponds to about 40g of syrup — a substantial serving. Lower doses may produce smaller effects. The crossover design with the same participants in both arms is a strength, as it controls for individual metabolic variation. Limitations include the exclusively female sample and the single-meal design, which does not address whether repeated daily use produces cumulative or adaptive effects on postprandial response.

Evidence Strength Summary

Yacon's prebiotic effects are well-supported across in vitro, animal, and human studies, with consistent promotion of beneficial gut bacteria and SCFA production at practical dietary doses [2][3]. The clinical evidence for insulin sensitization comes primarily from one 120-day RCT in a specific population, but the study design was rigorous and the effects were meaningful [1]. Acute postprandial blood sugar lowering has been confirmed in a crossover RCT at a dose of 14g FOS [4]. The overall evidence supports yacon FOS as a functional prebiotic with real effects on blood sugar regulation, best understood as an adjunct to a whole-foods diet rather than a standalone intervention. More diverse clinical trials — particularly in men, people with established type 2 diabetes, and populations with varying baseline gut microbiomes — are needed to generalize the findings more broadly.

References

Yacon syrup: beneficial effects on obesity and insulin resistance in humansGenta S, Cabrera W, Habib N, Pons J, Carillo IM, Grau A, Sánchez S. Clinical Nutrition, 2009. PubMed 19254816 →
Prebiotic effects of yacon (Smallanthus sonchifolius Poepp. & Endl), a source of fructooligosaccharides and phenolic compounds with antioxidant activityCampos D, Betalleluz-Pallardel I, Chirinos R, Aguilar-Galvez A, Noratto G, Pedreschi R. Food Chemistry, 2012. PubMed 22953898 →
Yacon (Smallanthus sonchifolius) as a Food Supplement: Health-Promoting Benefits of FructooligosaccharidesCaetano BF, de Moura NA, Almeida AP, Dias MC, Sivieri K, Barbisan LF. Nutrients, 2016. PubMed 27455312 →
Yacon syrup reduces postprandial glycemic response to breakfast: A randomized, crossover, double-blind clinical trialAdriano LS, Dionísio AP, Abreu FAP, Carioca AAF, Zocolo GJ, Wurlitzer NJ, Pinto CO, de Oliveira AC, Sampaio HAC. Food Research International, 2019. PubMed 31732062 →